¹û¶³ÊÓƵ, a private, clinical stage biotechnology company dedicated to addressing neuropsychiatric conditions through the novel application of psychedelic medicines, today announces that Cosmo Feilding Mellen, Chief Executive Officer, Steve Wooding, Chief Scientific Officer and Michael Norris, Chief Financial Officer, will attend the Jefferies London Healthcare Conference, being held in London from the 15th to the 17th of November 2022, and will hold a formal company presentation.
The presentation is scheduled to take place on Thursday, 17 November 2022, at 11.30 am GMT.
To request a one-on-one meeting with the ¹û¶³ÊÓƵ team, please contact gvanrenterghem@lifesciadvisors.com.
Links to other websites do not imply affiliation or endorsement. ¹û¶³ÊÓƵ does not control and is not responsible for their content.
.jpg)